Related Experiment Video

Updated: Feb 2, 2026

Quantitative Analysis of Alternative Pre-mRNA Splicing in Mouse Brain Sections Using RNA In Situ Hybridization Assay
11:22

Quantitative Analysis of Alternative Pre-mRNA Splicing in Mouse Brain Sections Using RNA In Situ Hybridization Assay

Published on: August 26, 2018

9.3K

Function, clinical application, and strategies of Pre-mRNA splicing in cancer

Cuixia Di1,2,3, Syafrizayanti4,5, Qianjing Zhang1,2,3

  • 1Department of Radiation Medicine, Institute of Modern Physics, Chinese Academy of Sciences, 730000, Lanzhou, China.

Cell Death and Differentiation
|November 23, 2018
PubMed

Insights

Aberrant splicing isoforms are crucial in cancer progression, affecting proliferation, metastasis, and apoptosis. Targeting these isoforms offers novel therapeutic strategies and diagnostic markers for cancer treatment.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Genetics

Background:

  • Pre-messenger RNA (pre-mRNA) splicing is essential for generating protein diversity.
  • Aberrant splicing is implicated in the pathology of various diseases, particularly cancers.
  • Splicing alterations significantly impact fundamental cancer processes.

Purpose of the Study:

  • To review the role of aberrant splicing isoforms in regulating cancer hallmarks: proliferation, metastasis, and apoptosis.
  • To discuss the clinical implications of aberrant splicing isoforms, including drug resistance and radiosensitivity.
  • To explore emerging therapeutic strategies targeting aberrant splicing isoforms and advancements in diagnostic methodologies.

Main Methods:

  • Literature review of studies on pre-mRNA splicing in cancer.
  • Analysis of aberrant splicing isoforms' impact on cancer hallmarks.
  • Evaluation of clinical relevance and therapeutic potential of targeting splicing isoforms.

Main Results:

  • Aberrant splicing isoforms precisely regulate cancer cell proliferation, metastasis, and apoptosis.
  • Aberrant splicing isoforms influence cancer treatment outcomes, affecting drug resistance and radiosensitivity.
  • Emerging strategies show promise for modulating aberrant splicing isoforms as novel cancer therapeutics.

Conclusions:

  • Aberrant splicing isoforms are significant biomarkers for cancer diagnosis and prognosis.
  • Targeting aberrant splicing isoforms represents a promising therapeutic avenue in oncology.
  • Further research into diagnostic methodologies for splicing isoforms is warranted.

More Related Videos

Using the E1A Minigene Tool to Study mRNA Splicing Changes10:25

Using the E1A Minigene Tool to Study mRNA Splicing Changes

Published on: April 22, 2021

5.5K
Pre-clinical Orthotopic Murine Model of Human Prostate Cancer07:01

Pre-clinical Orthotopic Murine Model of Human Prostate Cancer

Published on: August 29, 2016

15.0K

Related Concept Videos

Pre-mRNA Processing: RNA Splicing01:36

Pre-mRNA Processing: RNA Splicing

6.9K
Chromatin Structure Regulates pre-mRNA Processing02:41

Chromatin Structure Regulates pre-mRNA Processing

In eukaryotic cells, nascent mRNA transcripts need to undergo many post-transcriptional modifications to reach the cell cytoplasm and translate into functional proteins. For a long time, transcription and pre-mRNA processing were considered two independent events that occur sequentially in the cell. However, it has now been well established that transcription and pre-mRNA processing are two simultaneous processes that are precisely regulated inside the cell.
The chromatin structure, especially...
8.2K
pre-mRNA Processing02:01

pre-mRNA Processing

In eukaryotic cells, transcripts made by RNA polymerase are modified and processed before exiting the nucleus. Unprocessed RNA is called precursor mRNA or pre-mRNA to distinguish it from mature mRNA.
Once about 20-40 ribonucleotides have been joined together by RNA polymerase, a group of enzymes adds a “cap” to the 5’ end of the growing transcript. In this process, a 5’ phosphate is replaced by modified guanosine that has a methyl group attached to it (7-Methyl...
57.5K
Pre-mRNA Processing: Modification of pre-mRNA Ends01:35

Pre-mRNA Processing: Modification of pre-mRNA Ends

In eukaryotic cells, transcripts made by RNA polymerase are modified and processed before exiting the nucleus. Unprocessed RNA is called precursor mRNA or pre-mRNA to distinguish it from mature mRNA.
Once about 20-40 ribonucleotides have been joined together by RNA polymerase, a group of enzymes adds a cap to the 5' end of the growing transcript. In this process, a 5' phosphate is replaced by modified guanosine that has a methyl group attached (7-methyl guanosine). This 5' cap helps...
14.9K
Alternative RNA Splicing02:18

Alternative RNA Splicing

Alternative RNA splicing is the regulated splicing of exons and introns to produce different mature mRNAs from a single pre-mRNA. Unlike in constitutive splicing where a single gene produces a single type of mRNA, alternative splicing allows an organism to produce multiple proteins from a single gene and plays an important role in protein diversity.
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
25.2K
Nonsense-mediated mRNA Decay02:27

Nonsense-mediated mRNA Decay

The Upf proteins that carry out nonsense-mediated decay (NMD) are found in all eukaryotic organisms, including humans. Each protein has an individual role, but they need to work in collaboration. Upf1 is an ATP-dependent RNA helicase that unwinds the RNA helix. Because Upf1 can unwind any RNA, Upf2 and Upf3 are required to help Upf1 discriminate between nonsense and normal mRNAs.
Usually, Upf3 binds to an Exon Junction Complex (EJC) at mRNA splice sites. If a ribosome fully translates the mRNA,...
11.8K